The role of radical prostatectomy in high-risk prostate cancer

Heidenreich, 2011, EAU guidelines on prostate cancer. Part 1: screening, diagnosis, and treatment of clinically localised disease, Eur Urol, 59, 61, 10.1016/j.eururo.2010.10.039 Bosetti, 2011, Trends in mortality from urologic cancers in Europe, 1970-2008, Eur Urol, 60, 1, 10.1016/j.eururo.2011.03.047 Jemal, 2008, Cancer statistics, 2008, CA Cancer J Clin, 58, 71, 10.3322/CA.2007.0010 Sim, 2005, Changing demography of prostate cancer in Asia, Eur J Cancer, 41, 834, 10.1016/j.ejca.2004.12.033 Siegel, 2011, Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths, CA Cancer J Clin, 61, 212, 10.3322/caac.20121 Cooperberg, 2010, Time trends and local variation in primary treatment of localized prostate cancer, J Clin Oncol, 28, 1117, 10.1200/JCO.2009.26.0133 Thompson, 2006, Recommendations for defining and treating high risk localized prostate cancer, J Urol, 176, S6, 10.1016/j.juro.2006.09.016 Albertsen, 1995, Long-term survival among men with conservatively treated localized prostate cancer, JAMA, 274, 626, 10.1001/jama.1995.03530080042039 Albertsen, 2009, A challenge to contemporary management of prostate cancer, Nat Clin Pract Urol, 6, 12, 10.1038/ncpuro1270 Meng, 2005, Treatment of patients with high risk localized prostate cancer: results from cancer of the prostate strategic urological research endeavor (CaPSURE), J Urol, 173, 1557, 10.1097/01.ju.0000154610.81916.81 Garzotto, 2010, Contemporary management of high-risk localized prostate cancer, Curr Urol Rep, 11, 159, 10.1007/s11934-010-0101-0 D'Amico, 1998, Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer, JAMA, 280, 969, 10.1001/jama.280.11.969 Mohler, 2010, NCCN clinical practice guidelines in oncology: prostate cancer, J Natl Compr Canc Netw, 8, 162, 10.6004/jnccn.2010.0012 Roach, 2000, Four prognostic groups predict long-term survival from prostate cancer following radiotherapy alone on Radiation Therapy Oncology Group clinical trials, Int J Radiat Oncol Biol Phys, 47, 609, 10.1016/S0360-3016(00)00578-2 Kattan, 1998, A preoperative nomogram for disease recurrence following radical prostatectomy for prostate cancer, J Natl Cancer Inst, 90, 766, 10.1093/jnci/90.10.766 Cooperberg, 2005, The University of California, San Francisco Cancer of the Prostate Risk Assessment score: a straightforward and reliable preoperative predictor of disease recurrence after radical prostatectomy, J Urol, 173, 1938, 10.1097/01.ju.0000158155.33890.e7 Cooperberg, 2011, The CAPRA-S score: a straightforward tool for improved prediction of outcomes after radical prostatectomy, Cancer, 117, 5039, 10.1002/cncr.26169 Gerber, 1997, Results of radical prostatectomy in men with locally advanced prostate cancer: multi-institutional pooled analysis, Eur Urol, 32, 385, 10.1159/000480794 Grubb, 2010, High-risk localized prostate cancer: role of radical prostatectomy, Curr Opin Urol, 20, 204, 10.1097/MOU.0b013e3283384101 Stratton, 2009, Locally advanced prostate cancer: the role of surgical management, BJU Int, 104, 449, 10.1111/j.1464-410X.2009.08741.x Yossepowitch, 2008, Role of radical prostatectomy in the treatment of high-risk prostate cancer, Curr Urol Rep, 9, 203, 10.1007/s11934-008-0036-x Ingels, 2012, Radical prostatectomy as primary treatment of high-risk prostate cancer, Curr Urol Rep, 13, 179, 10.1007/s11934-012-0240-6 Gnanapragasam, 2012, The role of surgery in high-risk localised prostate cancer, BJU Int, 109, 648, 10.1111/j.1464-410X.2011.10596.x Bastian, 2012, High-risk prostate cancer: from definition to contemporary management, Eur Urol, 61, 1096, 10.1016/j.eururo.2012.02.031 Loeb, 2010, What are the outcomes of radical prostatectomy for high-risk prostate cancer?, Urology, 76, 710, 10.1016/j.urology.2009.09.014 Spahn, 2010, Outcome predictors of radical prostatectomy in patients with prostate-specific antigen greater than 20 ng/ml: a European multi-institutional study of 712 patients, Eur Urol, 58, 1, 10.1016/j.eururo.2010.03.001 Zwergel, 2007, Outcome of prostate cancer patients with initial PSA> or =20 ng/ml undergoing radical prostatectomy, Eur Urol, 52, 1058, 10.1016/j.eururo.2007.03.056 Hsu, 2007, Outcome of surgery for clinical unilateral T3a prostate cancer: a single-institution experience, Eur Urol, 51, 121, 10.1016/j.eururo.2006.05.024 Eggener, 2011, Predicting 15-year prostate cancer specific mortality after radical prostatectomy, J Urol, 185, 869, 10.1016/j.juro.2010.10.057 Boorjian, 2008, Impact of prostate-specific antigen testing on the clinical and pathological outcomes after radical prostatectomy for Gleason 8-10 cancers, BJU Int, 101, 299, 10.1111/j.1464-410X.2007.07269.x Ward, 2005, Radical prostatectomy for clinically advanced (cT3) prostate cancer since the advent of prostate-specific antigen testing: 15-year outcome, BJU Int, 95, 751, 10.1111/j.1464-410X.2005.05394.x Ploussard, 2010, Pathological findings and prostate-specific antigen outcomes after laparoscopic radical prostatectomy for high-risk prostate cancer, BJU Int, 106, 86, 10.1111/j.1464-410X.2009.09080.x Ploussard, 2011, Radical prostatectomy for high-risk prostate cancer defined by preoperative criteria: oncologic follow-up in national multicenter study in 813 patients and assessment of easy-to-use prognostic substratification, Urology, 78, 607, 10.1016/j.urology.2011.05.021 Bolla, 2005, Postoperative radiotherapy after radical prostatectomy: a randomised controlled trial (EORTC trial 22911), Lancet, 366, 572, 10.1016/S0140-6736(05)67101-2 Thompson, 2006, Adjuvant radiotherapy for pathologically advanced prostate cancer: a randomized clinical trial, JAMA, 296, 2329, 10.1001/jama.296.19.2329 Wiegel, 2009, Phase III postoperative adjuvant radiotherapy after radical prostatectomy compared with radical prostatectomy alone in pT3 prostate cancer with postoperative undetectable prostate-specific antigen: ARO 96-02/AUO AP 09/95, J Clin Oncol, 27, 2924, 10.1200/JCO.2008.18.9563 Bolla, 2012, Postoperative radiotherapy after radical prostatectomy for high-risk prostate cancer: long-term results of a randomised controlled trial (EORTC trial 22911), Lancet, 380, 2018, 10.1016/S0140-6736(12)61253-7 Swindle, 2005, Do margins matter? The prognostic significance of positive surgical margins in radical prostatectomy specimens, J Urol, 174, 903, 10.1097/01.ju.0000169475.00949.78 Messing, 2006, Immediate versus deferred androgen deprivation treatment in patients with node-positive prostate cancer after radical prostatectomy and pelvic lymphadenectomy, Lancet Oncol, 7, 472, 10.1016/S1470-2045(06)70700-8 Wirth, 2004, Prospective randomized trial comparing flutamide as adjuvant treatment versus observation after radical prostatectomy for locally advanced, lymph node-negative prostate cancer, Eur Urol, 45, 267, 10.1016/j.eururo.2003.10.013 McLeod, 2006, Bicalutamide 150 mg plus standard care vs standard care alone for early prostate cancer, BJU Int, 97, 247, 10.1111/j.1464-410X.2005.06051.x Siddiqui, 2011, Impact of adjuvant androgen deprivation therapy after radical prostatectomy on the survival of patients with pathological T3b prostate cancer, BJU Int, 107, 383, 10.1111/j.1464-410X.2010.09565.x Cooperberg, 2010, Comparative risk-adjusted mortality outcomes after primary surgery, radiotherapy, or androgen-deprivation therapy for localized prostate cancer, Cancer, 116, 5226, 10.1002/cncr.25456 Abdollah, 2011, A competing-risks analysis of survival after alternative treatment modalities for prostate cancer patients: 1988-2006, Eur Urol, 59, 88, 10.1016/j.eururo.2010.10.003 Arcangeli, 2009, Retrospective comparison of external beam radiotherapy and radical prostatectomy in high-risk, clinically localized prostate cancer, Int J Radiat Oncol Biol Phys, 75, 975, 10.1016/j.ijrobp.2008.12.045 Tewari, 2007, Long-term survival in men with high grade prostate cancer: a comparison between conservative treatment, radiation therapy and radical prostatectomy: a propensity scoring approach, J Urol, 177, 911, 10.1016/j.juro.2006.10.040 Westover, 2012, Radical prostatectomy vs radiation therapy and androgen-suppression therapy in high-risk prostate cancer, BJU Int, 110, 1116, 10.1111/j.1464-410X.2012.11012.x Boorjian, 2011, Long-term survival after radical prostatectomy versus external-beam radiotherapy for patients with high-risk prostate cancer, Cancer, 117, 2883, 10.1002/cncr.25900 Parikh, 2012, Primary radiotherapy versus radical prostatectomy for high-risk prostate cancer: a decision analysis, Cancer, 118, 258, 10.1002/cncr.26272